Results 121 to 130 of about 6,976 (207)

Still Treating Yesterday's Risk? Reconsidering Antiviral Use for Mild-to-Moderate COVID-19 Cases in a Broadly Immune Population. [PDF]

Med J Aust
Mudrik-Zohar H, Cutfield T, Morpeth S, Hills T, Duffy E, Edwards LJ, Cheng AC, Tong SYC.   +7 more
europepmc   +1 more source

Effectiveness of the Approved Nirmatrelvir/Ritonavir and Molnupiravir Regimens for Treatment of Mild/Moderate Laboratory-Confirmed SARS-CoV-2 Infection in Patients Aged 18-64 Years in Hong Kong: A Population-Based Cohort Study. [PDF]

Clin Drug Investig
Okoli GN, Lin Y, Wu P, Cowling BJ.
europepmc   +1 more source

Deep learning survival analysis with time-varying covariates: extending PyCox to assess COVID-19 antiviral treatments and long-COVID associations. [PDF]

JAMIA Open
Baik SH, Xian H, Baye F, Fung KW, McDonald CJ.   +4 more
europepmc   +1 more source

Is it "Time to Eliminate" Time to Elimination of Symptoms as a Primary Trial End Point for Drugs Targeting Respiratory Viruses? [PDF]

J Infect Dis
Schiffer JT, Esmaeili S, Owens K, Boeckh M, Waghmare A.   +4 more
europepmc   +1 more source

Treatment of acute COVID-19 in the community. [PDF]

Aust Prescr
Milliken E.
europepmc   +1 more source

Clinical Outcomes of Early Antiviral Treatment for COVID-19 in a Japanese Long-Term Care Facility With Limited Resources: A Retrospective Study of 107 Residents. [PDF]

Cureus
Kudeken N.
europepmc   +1 more source

Molnupiravir is effective against hepatitis E virus infection in an animal model. [PDF]

Hepatol Commun
Wu S, Chew NF, Ma X, Situ J, Shun EH, Li C, Ip JD, Ho SS, Zhang AJ, Tsoi JY, Chan WM, Ma W, Liang Y, Mao W, Chen KWY, Yin F, To KK, Yuan S, Chan JF, Zhu L, Huang Y, Sridhar S.   +21 more
europepmc   +1 more source

How Feasible is the Use of Saliva for Antiviral Therapeutic Drug Monitoring? A Systematic Review and Analysis. [PDF]

Clin Pharmacokinet
Lai CW, Wenker SAM, Groundwater PW, Beardsley J, Sutrave G, Chen RH, Märtson AG, Alffenaar JC.   +7 more
europepmc   +1 more source

<i>Boesenbergia rotunda</i>-Derived Phytochemicals as Potent Inhibitors of SARS-CoV-2 Papain-Like Protease (PLpro): Insights From Molecular Docking and Dynamic Simulation. [PDF]

Scientifica (Cairo)
Khan DA, Sheikh MA, Imon RR, Imtiaz M, Ahmed S, Gharami H, Labana RV, Jimoh TO, Gaurav A, Pereira ML, Nawaz M, Dungca JZ, Hasan MN, Ghosh M, Nissapatorn V.   +14 more
europepmc   +1 more source

Bio-inspired chemometric methods for simultaneous UV spectrophotometric determination of molnupiravir, nirmatrelvir, and favipiravir in pharmaceutical formulations and environmental samples. [PDF]

Sci Rep
Abdelzaher AM, Al Kamaly O, Rahman MAA.
europepmc   +1 more source